Practical Reviews

High-Dose Influenza Vaccination Reduces Risk of AD in Older Adults


Objective: To evaluate whether high-dose influenza vaccination is associated with reduced risk of Alzheimer dementia (AD) compared with standard-dose vaccination in older adults. Design: Large, retrospective cohort study. Methods: Using administrative and clinical data, the authors analyzed a population of Medicare beneficiaries aged ≥65 years, applying rigorous propensity score matching to minimize confounding. The primary outcome was incident AD over longitudinal follow-up. Results: High-dose influenza vaccination was associated with a statistically significant reduction in AD risk compared with standard-dose vaccination. The effect size was modest but consistent across multiple sensitivity analyses. Subgroup analyses suggested greater benefit among older age groups and individuals with higher baseline comorbidity burden. Conclusions: The authors propose that enhanced immune response from high-dose vaccination may mitigate neuroinflammatory pathways implicated in Alzheimer disea more...

Want to read the full article?

To view, you must be an active Practical Reviews subscriber.
Login or subscribe now.